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Background and Purpose—PHACE is an acronym for posterior fossa brain malformations, hemangiomas, arterial
anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Several case reports of arterial ischemic
stroke (AIS) in individuals with PHACE have been published, but risk factors for AIS in PHACE have not been clearly
defined. The objective of this article is to review all cases of stroke in PHACE in children and describe clinical
characteristics that may be associated with an increased risk of AIS.
Methods—A literature and registry search was conducted to identify patients with PHACE who had experienced AIS. Data
were analyzed to determine age of onset, presenting signs and symptoms, and clinical features among this cohort
compared with PHACE without AIS.
Results—Twenty-two individuals with PHACE and AIS were identified. Imaging of the arteries of the head and neck was
reported in 20 of 22. Narrowing or nonvisualization of at least 1 great cerebral vessel was present in 19 of 20 and of
those, 15 had 2 vessels involved. Aortic arch anomalies were reported in 13 of 22 individuals.
Conclusions—Aplasia, hypoplasia, or occlusion of a major cerebral artery appears to be a significant risk factor for AIS in children
with PHACE, especially when 1 vessel is involved or if there is coarctation of the aorta. (Stroke. 2012;43:1672-1674.)
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Frieden coined the term PHACE syndrome to describe theassociation of infantile hemangiomas of the head and
neck with developmental anomalies.1 PHACE is an acronym
for Posterior fossa brain malformations, Hemangiomas, Ar-
terial anomalies, Coarctation of the aorta and cardiac defects,
and Eye abnormalities. Approximately 30% of infants with
large, facial hemangiomas meet diagnostic criteria for defi-
nite PHACE with the most common extracutaneous finding
being abnormalities of the craniocervical arteries. The rela-
tionship between arteriopathy and arterial ischemic stroke
(AIS), a rare but devastating complication affecting a subset
of individuals with PHACE, is poorly understood.
In this study we review all known cases of PHACE-related
stroke to determine age of onset, presenting symptoms,
clinical characteristics, and associated comorbidities to fur-
ther understand potential risk factors.
Methods
This study was approved by the Institutional Review Board, Chil-
dren’s Hospital of Wisconsin. Scopus, PubMed, and Medline were
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used to conduct a literature review. Two clinical PHACE registries
and a panel of experts at a PHACE Syndrome Research Workshop
were queried for unpublished individuals.
Data Extraction and Methodologic Quality
Abstracts were reviewed to identify cases of stroke, and the relevant
articles were reviewed in full by 3 authors. A pediatric neurologist
(H.J.F.) independently reviewed the selected articles to confirm the
stroke diagnosis and data regarding cerebrovascular imaging. For
inclusion in this analysis, stroke was defined by (1) clinical symp-
toms such as sudden onset of focal neurological deficit, headaches,
loss of consciousness, or seizure; and (2) CT or MRI documenting a
large-territory infarct for arterial ischemic stroke or intracerebral,
subarachnoid, and/or intraventricular hemorrhage in a location and
of a maturity consistent with the neurological signs and symptoms.2
We included individuals in whom a remote yet symptomatic infarct
was diagnosed in a delayed fashion.3
Clinical Variables
Age at presentation of stroke, gender, presenting symptoms, neuro-
logical impairment poststroke, infarct distribution, and hemangioma
location were noted. Location, type, and severity of arteriopathy
were recorded as well as type of stroke. Also noted were the presence
of aortic arch anomaly, cardiac or arch surgery, and synthetic graft.
Finally, comorbidities and medication exposures were recorded
(online-only Data Supplement Table I).
Results
A total of 148 abstracts were identified in the initial literature
review. Thirty of those were selected for detailed review.
Using the previously mentioned definition of stroke, 11 of 30
articles (publication years 1998–2011) detailed individuals
with PHACE and stroke for a total of 18 cases.1,4–13 Four
unpublished cases were identified through registries and the
PHACE research workshop. Of these 22 cases, all had
presumed AIS. The age of onset, gender, presenting signs,
brain region, or arterial territory are summarized in the Table
and online-only Data Supplement Tables I and II.
Arteriopathy
Of the 22 individuals, 20 underwent imaging of the cervical
and intracranial arteries by MR angiography or conventional
angiogram. Of those 20, 19 (95%) had either narrowing or
nonvisualization of at least 1 great cerebral vessel; 15 of 20
(75%) had narrowing or nonvisualization in 2 vessels.
Dysgenesis was noted in 15 of 20 (75%), and in 5 of 20
(25%), dysgenesis affected 2 vessels. The presence of both
anterior and posterior circulation arteriopathy was present in
16 of 20 (80%). Moyamoya phenomenon was noted in 4 of 20
(20%). Four reports noted “progression” of arteriopathy. Four
individuals were treated with synangiosis.
Cardiac Anomalies
Cardiovascular findings were reported in 15 of 22 individu-
als. Aortic anomalies were noted in 13 of 15 with coarctation
(7), narrowing (3), interrupted arch (1), right arch (1), and
saccular aneurysm (1).
Structural Brain Anomalies
Posterior fossa abnormalities were present in 5 of 22 individ-
uals (23%), 2 with Dandy-Walker malformation and 3 with
cerebellar hypoplasia.
Hemangioma Location
Hemangiomas were located in the S1 (frontotemporal) seg-
ment in 17 of 22 (77%), S3 (mandibular) segment in 14 of 22
(64%), and S4 (frontonasal) segment in 7 of 22 (32%).
Extension to the scalp, posterior neck, or torso was noted in
11 of 22 (50%).
Medication Exposure
Medication exposure was reported in 14 individuals, all of
whom received corticosteroids. Additional medications in-
cluded vincristine, interferon, and propranolol. One subject
was treated for hypertension with amlodipine, aldactazide,
and nadolol.
Comorbidities
Prothrombotic workup was reported in 7 of 22. One was
positive for a homozygous C677T mutation of the methylene
tetrahydrofolate reductase gene. In 2 cases the stroke oc-
curred after infection, gastrointestinal illness in 1 and Listeria
monocytogenes meningitis in another.
Discussion
This literature and registry-based series reports a previously
underemphasized cause of AIS in childhood.1,5–14 There are 3
possible mechanisms for AIS with PHACE: (1) artery-to-
artery embolisms, in which a thrombus forms in a stenotic or
dysplastic cervical or cerebral artery, embolizes, then oc-
cludes a downstream cerebral artery; (2) ischemia from
reduced blood flow and inadequate cerebral perfusion (ie,
“watershed infarction”) distal to a flow-limiting arterial
stenosis or occlusion with inadequate collateralization (eg,
lack of intact circle of Willis and/or poor pial collaterals); or
(3) cardioembolisms due to structural abnormalities of the
heart or proximal aorta. As compared with previously pub-
lished PHACE case series, this current series of individuals
Table. Summary of Clinical Variables in PHACE With AIS
Timing of presenting symptoms of stroke
Delayed: 6/22
Acute: 15/22
Unknown: 1/22
Age at time of acute presentation (n15)
Range, 3 mo to 5 y
Median, 10.5 mo
Mean, 13.6 mo
Gender
Female: 18
Male: 4
Presenting symptoms of acute AIS (n15)
Seizures only: 3
Hemiparesis only: 5
Both seizures and hemiparesis: 6
Neurologic deterioration and death: 1
PHACE indicates Posterior fossa brain malformations, Hemangiomas, Arterial
anomalies, Coarctation of the aorta and cardiac defects, and Eye abnormalities;
AIS, arterial ischemic stroke.
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with PHACE-related stroke has a higher rate of aortic
anomalies; 59% versus 36%.14
The majority (21 of 22) had severe underlying arteriopathy.
More than 59% had nonvisualization of a major cerebral
artery compared with 20% of the Hess cohort of 70 patients
with PHACE with arterial anomalies.15 It is possible that the
higher proportion of patients with these imaging findings is
biased by the inherent pathophysiology of stroke with arterial
narrowing or occlusion at the time of symptoms reflecting
intravascular thrombus and/or the acute changes in blood
flow accompanying infarction. However, the extent of nar-
rowing or nonvisualization, presence of moyamoya collater-
als, and the frequent observation of these findings in an
arterial territory not directly related to the patient’s acute
symptoms mitigate against this possibility. Of those patients
with stroke and appropriate imaging of the arteries, none had
arterial dysplasia as the sole class of arteriopathy. Long-term
cohort studies with baseline imaging before the onset of
stroke symptoms are required to establish whether arterial
narrowing actually carries an inherently higher risk of devel-
oping AIS than other types of arteriopathy in PHACE.
Limitations of this study include its retrospective nature,
the lack of access to medical records and radiological images,
and the variability in imaging techniques used. Many reported
cases reviewed in this series had poststroke imaging only, and
as noted previously, nonvisualization of an artery after AIS
could represent either a congenitally hypoplastic or absent
artery or an acute embolic occlusion.
Conclusions
Children with PHACE have a high incidence of arteriopathy
(many with moyamoya phenomenon) that puts them at risk
for stroke. The majority of PHACE-related AIS cases with
neuroimaging had aplasia, hypoplasia, or occlusion of a
major cervical or cerebral artery. There was also a high
incidence of aortic arch anomalies. Stroke risk is likely
complex due to the potential contribution of the degree of
arterial stenosis, absence of an intact circle of Willis, and
coexisting aortic arch anomalies. Clinical studies are needed
to determine the impact of systemic therapies such as oral
corticosteroids and propranolol on the risk of demand-related
ischemia in patients with PHACE and severe arteriopathy.
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